MMED Share Price | Mind Medicine (MindMed), Inc. Stock Analysis & Recommendation

Q: What does Mind Medicine (MindMed), Inc. do?

Overview: Mind Medicine (MindMed), Inc. is a neuro-pharmaceutical company that discovers, develops, and deploys psychedelic-inspired medicines to improve health, promote wellness, and alleviate suffering, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.Financial Snapshot: Most recent Net Profit: -23 Million (Quarterly Results - Mar 2025) Market cap: USD 506.96 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.85 Return on Equity: -46.73% Price to Book: 2.28Contact Details: Address: 1166 Alberni Street, Suite 1604, VANCOUVER BC : V6E 3Z3 Tel: 1 604 7614689 Fax: 1 888 8483972 Website: http://broadwaymining.com/

Q: Is Mind Medicine (MindMed), Inc. technically bullish or bearish?

As of 19 September 2025, the technical trend for Mind Medicine (MindMed), Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a bullish MACD on the weekly timeframe and a bullish signal from Bollinger Bands on both weekly and monthly timeframes. However, the KST indicates a mildly bearish trend on the monthly, and Dow Theory shows a mildly bearish stance on the weekly. In terms of performance, the stock has returned 37.07% year-to-date and 59.80% over the past year, significantly outperforming the S&P 500, which returned 13.31% and 16.64% respectively in the same periods.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.72 M

Shareholding (Sep 2025)

FII

10.14%

Held by 72 FIIs

DII

75.19%

Held by 17 DIIs

Promoter

2.41%

How big is Mind Medicine (MindMed), Inc.?

22-Jun-2025

As of Jun 18, Mind Medicine (MindMed), Inc. has a market capitalization of 506.96 million and reported net sales of 0.00 million with a net profit of -77.62 million over the last four quarters. Shareholder's funds were 241.45 million, and total assets were 302.15 million.

View full answer

What does Mind Medicine (MindMed), Inc. do?

22-Jun-2025

Mind Medicine (MindMed), Inc. is a neuro-pharmaceutical company focused on developing psychedelic-inspired medicines for health and wellness. It has a market cap of approximately $506.96 million and reported a net profit loss of $23 million as of March 2025.

View full answer

Who are in the management team of Mind Medicine (MindMed), Inc.?

22-Jun-2025

As of March 2022, the management team of Mind Medicine (MindMed), Inc. includes Executive Chairman and Co-CEO Stephen Hurst, President and Director Miriam Wernli, and Co-CEO Jamon Rahn, along with independent directors Perry Dellelce, Stanley Glick, Bruce Linton, and Brigid Makes.

View full answer

Is Mind Medicine (MindMed), Inc. technically bullish or bearish?

23-Sep-2025

As of September 19, 2025, Mind Medicine (MindMed), Inc. has a mildly bullish trend, supported by a bullish MACD and Bollinger Bands, despite some bearish signals from KST and Dow Theory, with the stock returning 37.07% year-to-date and 59.80% over the past year, outperforming the S&P 500.

View full answer

Compare Mind Medicine (MindMed), Inc. with Similar Stocks

Puma Biotechnology, Inc.Adverum Biotechnologies, Inc.ESSA Pharma, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 1,689 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.29

Return on Equity

-111.39%

Price to Book

12.94

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-43 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

35.42%

6 Months

73.61%

1 Year

98.9%

2 Years

299.26%

3 Years

369.65%

4 Years

1350.89%

5 Years

-67.69%

Mind Medicine (MindMed), Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-259.88%

EBIT to Interest (avg)

-61.49

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.85

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

65.72%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.64

EV to EBIT

-3.50

EV to EBITDA

-3.50

EV to Capital Employed

12.29

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-351.44%

ROE (Latest)

-46.73%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 27 Schemes (12.26%)

Foreign Institutions

Held by 72 Foreign Institutions (10.14%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -623.73% vs 79.73% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-40.90",
          "val2": "-24.50",
          "chgp": "-66.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "0.50",
          "chgp": "360.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.20",
          "val2": "16.00",
          "chgp": "-113.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-42.70",
          "val2": "-5.90",
          "chgp": "-623.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -13.58% vs -68.49% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-103.40",
          "val2": "-90.70",
          "chgp": "-14.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.40",
          "val2": "-6.60",
          "chgp": "-103.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-108.70",
          "val2": "-95.70",
          "chgp": "-13.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-40.90

-24.50

-66.94%

Interest

2.30

0.50

360.00%

Exceptional Items

-2.20

16.00

-113.75%

Consolidate Net Profit

-42.70

-5.90

-623.73%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -623.73% vs 79.73% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-103.40

-90.70

-14.00%

Interest

2.30

0.00

Exceptional Items

-13.40

-6.60

-103.03%

Consolidate Net Profit

-108.70

-95.70

-13.58%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -13.58% vs -68.49% in Dec 2023

All Annual Results

Company CV

About Mind Medicine (MindMed), Inc.

Mind Medicine (MindMed), Inc.

Pharmaceuticals & Biotechnology

Mind Medicine (MindMed) Inc., formerly Broadway Gold Mining Ltd., is a neuro-pharmaceutical company. The Company discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The Company addresses the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Company Coordinates

Company Details

1166 Alberni Street, Suite 1604 , VANCOUVER BC : V6E 3Z3

Tel: 1 604 7614689

http://broadwaymining.com/

Registrar Details

Mind Medicine (MindMed), Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Mind Medicine (MindMed), Inc.?

Watch in Real-Time

What does Mind Medicine (MindMed), Inc. do?

Who are in the management team of Mind Medicine (MindMed), Inc.?

Is Mind Medicine (MindMed), Inc. technically bullish or bearish?

Compare Mind Medicine (MindMed), Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Mind Medicine (MindMed), Inc.

Company Coordinates